Cargando…

Is the combination of immunotherapy with conventional chemotherapy the key to increase the efficacy of colorectal cancer treatment?

Colorectal cancer (CRC) is among the most prevalent and deadly neoplasms worldwide. According to GLOBOCAN predictions, its incidence will increase from 1.15 million CRC cases in 2020 to 1.92 million cases in 2040. Therefore, a better understanding of the mechanisms involved in CRC development is nec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Olguin, Jonadab E, Mendoza-Rodriguez, Monica G, Sanchez-Barrera, C Angel, Terrazas, Luis I
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9994043/ https://www.ncbi.nlm.nih.gov/pubmed/36908325 http://dx.doi.org/10.4251/wjgo.v15.i2.251

Ejemplares similares

Relevance of Regulatory T Cells during Colorectal Cancer Development
por: Olguín, Jonadab E., et al.
Publicado: (2020)

STAT1-Dependent Recruitment of Ly6C(hi)CCR2(+) Inflammatory Monocytes and M2 Macrophages in a Helminth Infection
por: Becerra-Díaz, Mireya, et al.
Publicado: (2021)

Helminth Products Potently Modulate Experimental Autoimmune Encephalomyelitis by Downregulating Neuroinflammation and Promoting a Suppressive Microenvironment
por: Peón, Alberto N., et al.
Publicado: (2017)

STAT6 Is Critical for the Induction of Regulatory T Cells In Vivo Controlling the Initial Steps of Colitis-Associated Cancer
por: Delgado-Ramirez, Yael, et al.
Publicado: (2021)

MIF Promotes Classical Activation and Conversion of Inflammatory Ly6C(high) Monocytes into TipDCs during Murine Toxoplasmosis
por: Ruiz-Rosado, Juan de Dios, et al.
Publicado: (2016)

Deficiency in STAT1 Signaling Predisposes Gut Inflammation and Prompts Colorectal Cancer Development
por: Leon-Cabrera, Sonia, et al.
Publicado: (2018)

Recruitment of M1 Macrophages May Not Be Critical for Protection against Colitis-Associated Tumorigenesis
por: Medina-Andrade, Itzel, et al.
Publicado: (2021)

Mexican Colorectal Cancer Research Consortium (MEX-CCRC): Etiology, Diagnosis/Prognosis, and Innovative Therapies
por: Andrade-Meza, Antonio, et al.
Publicado: (2023)

A Dual Role for Macrophages in Modulating Lung Tissue Damage/Repair during L2 Toxocara canis Infection
por: Faz-López, Berenice, et al.
Publicado: (2019)

Dual activation profile of monocytes is associated with protection in Mexican patients during SARS-CoV-2 disease
por: Acosta-Altamirano, Gustavo, et al.
Publicado: (2022)

Combining conventional chemotherapy and γδ T cell-based immunotherapy to target cancer-initiating cells
por: Todaro, Matilde, et al.
Publicado: (2013)

Can immunotherapy reinforce chemotherapy efficacy? a new perspective on colorectal cancer treatment
por: He, Xing, et al.
Publicado: (2023)

Extraintestinal Helminth Infection Limits Pathology and Proinflammatory Cytokine Expression during DSS-Induced Ulcerative Colitis: A Role for Alternatively Activated Macrophages and Prostaglandins
por: Ledesma-Soto, Yadira, et al.
Publicado: (2015)

STAT1 Is Required for Decreasing Accumulation of Granulocytic Cells via IL-17 during Initial Steps of Colitis-Associated Cancer
por: Delgado-Ramirez, Yael, et al.
Publicado: (2021)

Reduction of Foxp3(+) Cells by Depletion with the PC61 mAb Induces Mortality in Resistant BALB/c Mice Infected with Toxoplasma gondii
por: Tenorio, Eda Patricia, et al.
Publicado: (2010)

Pramlintide, an antidiabetic, is antineoplastic in colorectal cancer and synergizes with conventional chemotherapy
por: Al-Keilani, Maha S, et al.
Publicado: (2018)

Retrospective analysis of the efficacy of cytokine‐induced killer cell immunotherapy combined with first‐line chemotherapy in patients with metastatic colorectal cancer
por: Pan, Qiu‐Zhong, et al.
Publicado: (2020)

Retrospective analysis of the efficacy of adjuvant cytokine‐induced killer cell immunotherapy combined with chemotherapy in colorectal cancer patients after surgery
por: Li, Xiao, et al.
Publicado: (2022)

How to Increase the Efficacy of Immunotherapy in NSCLC and HNSCC: Role of Radiation Therapy, Chemotherapy, and Other Strategies
por: Nardone, Valerio, et al.
Publicado: (2018)

Overview of New Treatments with Immunotherapy for Breast Cancer and a Proposal of a Combination Therapy
por: Galván Morales, Miguel Angel, et al.
Publicado: (2020)

MGL1 Receptor Plays a Key Role in the Control of T. cruzi Infection by Increasing Macrophage Activation through Modulation of ERK1/2, c-Jun, NF-κB and NLRP3 Pathways
por: Rodriguez, Tonathiu, et al.
Publicado: (2020)

The safety and efficacy of chemotherapy combined with immunotherapy for pancreatic cancer: A meta-analysis
por: Huang, Yang, et al.
Publicado: (2021)

Efficacy of DC-CIK Immunotherapy Combined with Chemotherapy on Locally Advanced Gastric Cancer
por: Liu, Guiyuan, et al.
Publicado: (2022)

Efficacy and safety analysis of chemotherapy combined with immunotherapy compared with standard chemotherapy for advanced biliary tract malignant tumors
por: Zhang, Zhengfeng, et al.
Publicado: (2023)

Increased Nuclear FOXP2 Is Related to Reduced Neural Stem Cell Number and Increased Neurogenesis in the Dorsal Telencephalon of Embryos of Diabetic Rats through Histamine H(1) Receptors
por: De la Merced-García, Diana Sarahi, et al.
Publicado: (2023)

Early and Partial Reduction in CD4(+)Foxp3(+) Regulatory T Cells during Colitis-Associated Colon Cancer Induces CD4(+) and CD8(+) T Cell Activation Inhibiting Tumorigenesis
por: Olguín, Jonadab E., et al.
Publicado: (2018)

Blood microbiota diversity determines response of advanced colorectal cancer to chemotherapy combined with adoptive T cell immunotherapy
por: Yang, Duo, et al.
Publicado: (2021)

SCG2: A Prognostic Marker That Pinpoints Chemotherapy and Immunotherapy in Colorectal Cancer
por: Weng, Siyuan, et al.
Publicado: (2022)

Targeting iNOS to increase efficacy of immunotherapies
por: Ekmekcioglu, Suhendan, et al.
Publicado: (2017)

Efficacy of zinc carnosine in the treatment of colorectal cancer and its potential in combination with immunotherapy in vivo
por: Tang, Weiwei, et al.
Publicado: (2022)

Short-term efficacy and influencing factors of conventional chemotherapy combined with irinotecan in patients with advanced gastric cancer
por: Wang, Jun-Ping, et al.
Publicado: (2023)

Targeting chemotherapy-resistant leukemia by combining DNT cellular therapy with conventional chemotherapy
por: Chen, Branson, et al.
Publicado: (2018)

Does the Microbiota Composition Influence the Efficacy of Colorectal Cancer Immunotherapy?
por: Lin, Yan, et al.
Publicado: (2022)

Prediction of immunotherapy efficacy and immunomodulatory role of hypoxia in colorectal cancer
por: Zheng, Zhuangzhuang, et al.
Publicado: (2022)

Plant-Derived Bioactive Compounds in Colorectal Cancer: Insights from Combined Regimens with Conventional Chemotherapy to Overcome Drug-Resistance
por: Gavrilas, Laura Ioana, et al.
Publicado: (2022)

Comparative Efficacy and Safety of Immunotherapy Alone and in Combination With Chemotherapy for Advanced Non-small Cell Lung Cancer
por: Wang, Xue, et al.
Publicado: (2021)

Efficacy and safety of neoadjuvant immunotherapy combined with chemotherapy in locally advanced esophageal cancer: A meta-analysis
por: Wang, Jincheng, et al.
Publicado: (2022)

Bifidobacterium breve predicts the efficacy of anti‐PD‐1 immunotherapy combined with chemotherapy in Chinese NSCLC patients
por: Zhao, Honghui, et al.
Publicado: (2022)

MDSC-decreasing chemotherapy increases the efficacy of cytokine-induced killer cell immunotherapy in metastatic renal cell carcinoma and pancreatic cancer
por: Wang, Zibing, et al.
Publicado: (2015)

Radiotherapy: the key to immunotherapy ignition?
por: Luterstein, Elaine, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_q4ei8elktf9c9m586p9253h50o